Republic Bank (Ghana) PLC (GHSE:RBGH)
1.050
0.00 (0.00%)
At close: Aug 1, 2025
Verve Therapeutics Income Statement
Financials in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 1,245 | 1,202 | 975.43 | 625.16 | 482.67 | 468.23 | Upgrade |
Interest Paid on Deposits | 547.9 | 552.12 | 417.87 | 232.23 | 179.42 | 197 | Upgrade |
Net Interest Income | 697.04 | 650.15 | 557.56 | 392.92 | 303.25 | 271.23 | Upgrade |
Net Interest Income Growth (YoY) | 13.59% | 16.61% | 41.90% | 29.57% | 11.81% | 16.43% | Upgrade |
Income From Trading Activities | 64.08 | 49.92 | 55.22 | 34.01 | 27.85 | 20.3 | Upgrade |
Gain (Loss) on Sale of Assets | 1.14 | 1.14 | 0.08 | 0.73 | 2.29 | -0.01 | Upgrade |
Gain (Loss) on Sale of Investments | 6.32 | 5.33 | -3.05 | 4.69 | 4.09 | 5.34 | Upgrade |
Other Non-Interest Income | 172.37 | 162.62 | 139.27 | 118.75 | 88.53 | 81.25 | Upgrade |
Total Non-Interest Income | 243.91 | 219.02 | 191.52 | 158.18 | 122.75 | 106.88 | Upgrade |
Non-Interest Income Growth (YoY) | 26.20% | 14.36% | 21.08% | 28.86% | 14.85% | -2.84% | Upgrade |
Revenues Before Loan Losses | 940.95 | 869.17 | 749.08 | 551.1 | 426.01 | 378.11 | Upgrade |
Provision for Loan Losses | 21.5 | 31.61 | 66.09 | 241.61 | 20.45 | 48.16 | Upgrade |
919.45 | 837.56 | 682.99 | 309.5 | 405.56 | 329.95 | Upgrade | |
Revenue Growth (YoY) | 26.18% | 22.63% | 120.68% | -23.69% | 22.92% | 1.89% | Upgrade |
Salaries and Employee Benefits | 303.29 | 283.41 | 233.73 | 186.37 | 152.68 | 144.98 | Upgrade |
Occupancy Expenses | 49.32 | 43.56 | 34.8 | 26.93 | 22.86 | 21.46 | Upgrade |
Selling, General & Administrative | 14.93 | 14.9 | 11.82 | 12.64 | 11.19 | 7.86 | Upgrade |
Other Non-Interest Expense | 216.91 | 198.09 | 174.36 | 99.41 | 92.97 | 72.77 | Upgrade |
Total Non-Interest Expense | 584.44 | 539.96 | 454.71 | 325.36 | 279.7 | 247.07 | Upgrade |
EBT Excluding Unusual Items | 335.01 | 297.6 | 228.28 | -15.86 | 125.86 | 82.88 | Upgrade |
Pretax Income | 335.01 | 297.6 | 228.28 | -15.86 | 125.86 | 82.88 | Upgrade |
Income Tax Expense | 96.69 | 86.92 | 83.24 | 45.27 | 35.98 | 26.34 | Upgrade |
Earnings From Continuing Operations | 238.32 | 210.68 | 145.03 | -61.13 | 89.88 | 56.54 | Upgrade |
Minority Interest in Earnings | -10.27 | -8.81 | -5.01 | -2.55 | -1.64 | -0.12 | Upgrade |
Net Income | 228.06 | 201.87 | 140.03 | -63.68 | 88.24 | 56.41 | Upgrade |
Net Income to Common | 228.06 | 201.87 | 140.03 | -63.68 | 88.24 | 56.41 | Upgrade |
Net Income Growth | 52.62% | 44.16% | - | - | 56.41% | -27.93% | Upgrade |
Basic Shares Outstanding | - | 852 | 852 | 852 | 852 | 852 | Upgrade |
Diluted Shares Outstanding | - | 852 | 852 | 852 | 852 | 852 | Upgrade |
EPS (Basic) | - | 0.24 | 0.16 | -0.07 | 0.10 | 0.07 | Upgrade |
EPS (Diluted) | - | 0.24 | 0.16 | -0.07 | 0.10 | 0.07 | Upgrade |
EPS Growth | - | 44.14% | - | - | 56.45% | -27.95% | Upgrade |
Effective Tax Rate | 28.86% | 29.21% | 36.47% | - | 28.59% | 31.79% | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.